What is QTest Labs?
QTest Labs operates as a specialized Contract Research Organization (CRO) dedicated to bridging the gap between drug discovery and pre-clinical trials. The company's core expertise lies in enhancing the safety and efficacy of pharmaceuticals and medical devices, with a particular focus on cardiovascular safety and risk assessment. By employing cutting-edge science and technology, QTest Labs aims to accelerate the understanding of test articles and provide predictive efficacy and safety testing solutions. Their approach seeks to move beyond traditional regulatory constraints, offering comprehensive research and clear, actionable insights to pharmaceutical and medical device companies.
How much funding has QTest Labs raised?
QTest Labs has raised a total of $379K across 2 funding rounds:
Debt
$150K
Debt
$229K
Debt (2020): $150K with participation from PPP
Debt (2021): $229K led by PPP
Key Investors in QTest Labs
PPP
Public-Private Partnership
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for QTest Labs?
The recent large-scale late-stage funding indicates QTest Labs is poised for significant expansion and further development of its research capabilities. This strategic investment will likely fuel advancements in their cardiovascular safety and risk assessment platforms, potentially enabling the company to broaden its service offerings and client base. QTest Labs is well-positioned to capitalize on the growing demand for predictive and efficient pre-clinical testing, reinforcing its role as a key player in the drug development ecosystem.
See full QTest Labs company page
